Envoy Medical, Inc. financial data

Symbol
COCH, COCHW on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
4875 White Bear Parkway, White Bear Lake, Minnesota
Fiscal year end
December 31
Former names
Anzu Special Acquisition Corp I (to 9/29/2023)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 116 % +907%
Quick Ratio 17 %
Debt-to-equity -363 % -464%
Return On Equity 325 % +219%
Return On Assets -124 % -310%
Operating Margin -6.58K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19.6M shares
Common Stock, Shares, Outstanding 19.5M shares
Weighted Average Number of Shares Outstanding, Basic 19.6M shares +93.6%
Weighted Average Number of Shares Outstanding, Diluted 19.6M shares +93.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 302K USD +7.94%
Research and Development Expense 9.83M USD +20.3%
Selling and Marketing Expense 497K USD +29.8%
General and Administrative Expense 1.6M USD -13.6%
Costs and Expenses 20.2M USD +8.48%
Operating Income (Loss) -19.9M USD -36.5%
Nonoperating Income (Expense) 6.25M USD
Net Income (Loss) Attributable to Parent -13.6M USD +65.3%
Earnings Per Share, Basic -0.35 USD/shares +79.4%
Earnings Per Share, Diluted -0.35 USD/shares +79.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.22M USD +2205%
Accounts Receivable, after Allowance for Credit Loss, Current 174K USD
Inventory, Net 1.58M USD
Assets, Current 5M USD +1156%
Property, Plant and Equipment, Net 632K USD
Assets 6.74M USD -85%
Accounts Payable, Current 1.59M USD +11%
Accrued Liabilities, Current 6M USD +17.2%
Liabilities, Current 8.06M USD -13.8%
Liabilities 19.1M USD -9.95%
Accumulated Other Comprehensive Income (Loss), Net of Tax -120K USD
Retained Earnings (Accumulated Deficit) -270M USD -1200%
Stockholders' Equity Attributable to Parent -12.4M USD +72.5%
Liabilities and Equity 6.74M USD -85%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.85M USD -94.2%
Net Cash Provided by (Used in) Financing Activities 6.68M USD +67.1%
Net Cash Provided by (Used in) Investing Activities -109K USD -84.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 727K USD -21.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.75M USD +2468%
Deferred Tax Assets, Valuation Allowance 5.78M USD +796%
Deferred Tax Assets, Gross 50.2M USD +13.1%
Operating Lease, Liability 1.3M USD
Depreciation 34K USD +25.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.6M USD +70.2%
Lessee, Operating Lease, Liability, to be Paid 1.32M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 223K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 229K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 230K USD
Deferred Tax Assets, Operating Loss Carryforwards 41.2M USD +2.13%
Preferred Stock, Shares Issued 100M shares
Unrecognized Tax Benefits 516K USD -5.32%
Lessee, Operating Lease, Liability, to be Paid, Year Four 195K USD
Additional Paid in Capital 258M USD
Preferred Stock, Shares Outstanding 4.5M shares
Deferred Tax Assets, Net of Valuation Allowance 50.2M USD +13.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%